Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers.

Yapar Gümüş C, Yurdakul Ertürk E, Kaşko Arıcı Y, Altınok Eİ, Bayrak T, Bayrak A, Kasar T

Open source

DOI
10.3389/fped.2026.1844353
Published
2026
Container
Frontiers in pediatrics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2026.1844353,
  title = {Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers.},
  author = {Yapar Gümüş C and Yurdakul Ertürk E and Kaşko Arıcı Y and Altınok Eİ and Bayrak T and Bayrak A and Kasar T},
  year = {2026},
  journal = {Frontiers in pediatrics},
  doi = {10.3389/fped.2026.1844353},
  url = {https://doi.org/10.3389/fped.2026.1844353}
}

RIS

TY  - JOUR
TI  - Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers.
AU  - Yapar Gümüş C
AU  - Yurdakul Ertürk E
AU  - Kaşko Arıcı Y
AU  - Altınok Eİ
AU  - Bayrak T
AU  - Bayrak A
AU  - Kasar T
PY  - 2026
JO  - Frontiers in pediatrics
DO  - 10.3389/fped.2026.1844353
UR  - https://doi.org/10.3389/fped.2026.1844353
ER  - 

APA

C, Y. G., E, Y. E., Y, K. A., Eİ, A., T, B., A, B., & T, K. (2026). Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers.. Frontiers in pediatrics. https://doi.org/10.3389/fped.2026.1844353

Source records